Arthur H. Amron, Director at NEPHROS INC (NEPH), bought 5,000 shares at $2.22 ($11K) on 2024-05-28, disclosed to the SEC on 2024-05-30.
Open-market purchase of $11k NEPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.22 | 2,000 | $4K | 39.8% |
| 2 | $2.24 | 3,000 | $7K | 60.2% |
| Total | $2.23 avg | 5,000 | $11K | 100% |
| Filing → |
| TUSK | BUY | 2025-12-15 | $19K | — | Filing → |
| TUSK | BUY | 2024-12-16 | $3K | — | Filing → |
| TUSK | BUY | 2024-05-30 | $18K | — | Filing → |